Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Thursday, 1st April, 2021 till 48 hours after the end of the Board Meeting wherein; the approval of Audited Financial Results for the quarter and financial year ended 31st March, 2021, would be considered, approved and declared. Fredun Pharmaceuticals Ltd - 539730 - Announcement Under Regulation 30 (LODR)- Company''s Way Forward
Please find attached Corporate Presentation. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Nine months ended December 31, 2020; as approved by the Board in its Meeting held on Friday, February 12, 2021; published in Financial Express & Mumbai Lakshadeep newspaper(s) on Sunday, February 14, 2021. Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting Held On 12Th February,2021
In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; we wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, February 12, 2021; had considered and approved the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2020 Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Friday, February 12, 2021 at 3:00 P.M.; published in Business Standard & Mumbai Lakshadeep newspapers on January 29, 2021. Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December,2020
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 12, 2021 at 3:00 P.M. at the Registered Office of the Company interalia to discuss, consider and approve the Unaudited Financial Results of the Company for the Quarter and nine months ended December 31, 2020. Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended December 31, 2020
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended December 31, 2020.